All Featured Insights

Shutdown ends, Moody’s outlook for not-for-profit hospitals for 2026, Canada loses measles elimination status.

Signs of interest in federal regulation of health AI, new warning issued about antibiotic resistance, White House announces drug pricing deal.

Trump and the FDA weigh in on Tylenol, worries about ACA premium tax cut extension come to a head, a new normal with cybersecurity

Turmoil in the nation’s public health agency leads to turmoil in vaccine policy, Medicare dips its toes into the prior-authorization waters.

CBO finds OBBB could lead to Medicare cuts, employers expecting major healthcare cost increases in 2026, competing immunization guidelines.

HHS cancels mRNA contracts, insurance troubles create an opening for IDNs, Gates Foundation announces major women’s health initiative.

UnitedHealth’s difficulties continue, more doctors exit traditional Medicare, troubling new report on hospital safety reporting

All ACIP committee members dismissed, dozens of states sue 23andMe, FDA to use AI in drug approvals

CBO releases coverage impacts of One Big Beautiful Bill, 5th Circuit to rehear No Surprises Act challenge, many Epic customers live on TEFCA.

Trump administration continues transparency push, Hinge Health’s splash IPO, CMS looks for Medicare Advantage fraud.

This week’s graphic highlights UnitedHealth Group’s recent financial difficulties—which the large healthcare conglomerate did not fully anticipate.

Trump administration releases 2026 budget, President Trump to boost domestic pharmaceutical manufacturing, Rite Aid declares bankruptcy again.